Sound Income Strategies, LLC Abb Vie Inc. Transaction History

Sound Income Strategies, LLC

$1.27 Billion
Q2 2024

A detailed history of Sound Income Strategies, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sound Income Strategies, LLC holds 105,962 shares of ABBV stock, worth $20.5 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

105,962

Previous 102,264 3.62%

Holding current value

$20.5 Million

Previous $18.6 Million 2.41%

% of portfolio

1.43%

Previous 1.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$154.79 - $180.76 $572,413 - $668,450	3,698 Added 3.62%	105,962 $18.2 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $1.46 Million - $1.66 Million	9,140 Added 9.81%	102,264 $18.6 Million
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $4.34 Million - $4.88 Million	-31,521 Reduced 25.29%	93,124 $14.4 Million
Q3 2023 Oct 12, 2023	BUY	$133.59 - $154.65 $1.24 Million - $1.44 Million	9,293 Added 8.06%	124,645 $18.6 Million
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $286,619 - $356,678	-2,163 Reduced 1.84%	115,352 $15.5 Million
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $1.98 Million - $2.28 Million	13,719 Added 13.22%	117,515 $18.7 Million
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $1.43 Million - $1.71 Million	10,324 Added 11.05%	103,796 $0
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $1.16 Million - $1.32 Million	8,606 Added 10.14%	93,472 $12.5 Million
Q2 2022 Jul 11, 2022	BUY	$137.62 - $174.96 $283,221 - $360,067	2,058 Added 2.49%	84,866 $13 Million
Q1 2022 Apr 11, 2022	BUY	$131.98 - $163.75 $121,421 - $150,650	920 Added 1.12%	82,808 $13.4 Million
Q4 2021 Jan 13, 2022	BUY	$107.43 - $135.93 $494,178 - $625,278	4,600 Added 5.95%	81,888 $11.1 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $1.11 Million - $1.26 Million	10,449 Added 15.63%	77,288 $8.34 Million
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $691,124 - $769,952	6,569 Added 10.9%	66,839 $7.53 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $1.77 Million - $1.95 Million	17,303 Added 40.27%	60,270 $6.52 Million
Q4 2020 Jan 11, 2021	BUY	$80.49 - $108.67 $739,300 - $998,133	9,185 Added 27.19%	42,967 $4.6 Million
Q3 2020 Oct 08, 2020	BUY	$85.91 - $100.83 $304,894 - $357,845	3,549 Added 11.74%	33,782 $2.96 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $192,449 - $257,526	2,623 Added 9.5%	30,233 $2.97 Million
Q1 2020 Apr 07, 2020	BUY	$64.5 - $97.79 $258,064 - $391,257	4,001 Added 16.95%	27,610 $2.1 Million
Q4 2019 Jan 06, 2020	BUY	$72.13 - $90.25 $169,577 - $212,177	2,351 Added 11.06%	23,609 $2.09 Million
Q3 2019 Oct 04, 2019	BUY	$62.98 - $75.72 $239,386 - $287,811	3,801 Added 21.77%	21,258 $1.61 Million
Q2 2019 Jul 16, 2019	BUY	$65.7 - $83.98 $321,338 - $410,746	4,891 Added 38.92%	17,457 $1.27 Million
Q1 2019 Apr 04, 2019	BUY	$77.14 - $90.79 $34,404 - $40,492	446 Added 3.68%	12,566 $1.01 Million
Q4 2018 Jan 11, 2019	BUY	$77.85 - $96.01 $17,671 - $21,794	227 Added 1.91%	12,120 $1.12 Million
Q4 2018 Jan 10, 2019	SELL	$77.85 - $96.01 $17,127 - $21,122	-220 Reduced 1.82%	11,893 $1.04 Million
Q4 2018 Jan 08, 2019	SELL	$77.85 - $96.01 $49,434 - $60,966	-635 Reduced 4.98%	12,113 $1.15 Million
Q3 2018 Oct 03, 2018	BUY	$88.91 - $98.84 $359,818 - $400,005	4,047 Added 46.51%	12,748 $1.21 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $132,335 - $156,583	1,474 Added 20.4%	8,701 $806,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $31,835 - $42,630	346 Added 5.03%	7,227 $684,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $616,262 - $675,783	6,881	6,881 $770,000

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.

Account

Sound Income Strategies, LLC Abb Vie Inc. Transaction History